Vaxart Awarded $9.27 Mill Funding for Phase 2b Trial of Oral Pill COVID-19 Vaccine
American clinical-stage biotechnology company Vaxart, Inc. has announced that the United States Biomedical Advanced Research and Development Authority (BARDA) granted
Read more